Evidence map›Paper›PMID 40389686›Full record

ArticleChirurgie (Heidelberg, Germany)2025

[Update on medullary thyroid carcinoma-What is relevant for surgeons?]

Kerstin Lorenz, Andreas Machens, Henning Dralle

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Chirurgie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Thyroid Cancer: Epidemiology, Diagnosis, and Treatment.Deutsches Arzteblatt international · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kerstin LorenzKlinik für Viszerale, Gefäß- und Endokrine Chirurgie, Universitätsmedizin Halle, Ernst-Grube-Str. 40, 06120, Halle/Saale, Deutschland. kerstin.lorenz@uk-halle.de.ORCID http://orcid.org/0000-0003-0281-1950
Andreas MachensKlinik für Viszerale, Gefäß- und Endokrine Chirurgie, Universitätsmedizin Halle, Ernst-Grube-Str. 40, 06120, Halle/Saale, Deutschland.
Henning DralleKlinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Division Endokrine Chirurgie, Universität Duisburg-Essen, Essen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article provides an overview of surgically relevant diagnostic and operative aspects of medullary thyroid carcinoma (MTC) regarding current trends from recent studies and the expected adaptation of national S3 guidelines. The article addresses individual patient treatment options based on recognizable risk factors, the intraoperative resection strategy and standard procedures as well as the characteristics of sporadic and hereditary MTC with the concept of prophylactic thyroidectomy.

Indexed as

Carcinoma, MedullaryThyroidectomyThyroid NeoplasmsCarcinoma, NeuroendocrineHumansPractice Guidelines as TopicRisk FactorsCalcitoninDesmoplasiaLymph node dissectionProphylactic thyroidectomyRisk-stratified surgery

Identifiers

PMID40389686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.